News & Events

News

Read more about our scientific studies as well as our programs, grants and awards.
News
Improving Global Access to Transplantation: A Decade of the DKMS ATT Program
In a recent paper in Blood Global Hematology we reflect on more than ten years of the successful Access to Transplantation (ATT) program, launched by DKMS in 2014. Read more about our activities and what we achieved in the last decade.
News
Honoring Scientific Excellence at the DKMS Awards Night
At the Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Madrid, we came together with leading experts in hematology and transplantation to celebrate scientific excellence and future innovation. Under the theme “35 Years of Science at DKMS,” we presented the 2026 DKMS Mechtild Harf Science Award to Robert Negrin and young scientists were awarded with the DKMS John Hansen Research Grant.
News
New data on donor selection in allogeneic stem cell transplantation – young age is gaining in importance
The compatibility of relevant characteristics of human leukocyte antigens (HLA) is considered the most important criteria for selecting donors for allogeneic hematopoietic stem cell transplantation. Current study data presented by DKMS at the DGHO Annual Meeting 2025 in Cologne, Germany, indicate that the biological age of donors has a greater influence on transplant success than previously assumed [1]. “Our results show that we need to reevaluate the established standard for donor selection,” emphasizes Prof. Dr. Johannes Schetelig, Head of the Stem Cell Transplantation Unit at the University Hospital Carl Gustav Carus Dresden and Director Clinical Research at DKMS. The international non-profit organization, which is dedicated to supporting people with blood cancer and blood disorders, promotes medical progress through its own research work. With its campaigns, it aims to encourage young people aged 17 and older to register with the world's largest stem cell donor database.

Events

Find here all upcoming events.
-
Listen to the first data on the GRAPPA trial at the EHA 2026 in Stockholm
Stockholmsmässan

In addition to other contributions from DKMS we are happy to announce the presentation of the first data from GRAPPA, a randomized clinical trial comparing PTCy vs ATG, during the EHA Congress 2026 in Stockholm, Sweden.

Presentation: Pro ATG
Prof. Johannes Schetelig (Dresden, Germany)
Date & time: Saturday, 13 June, 16:20- 16:25 CEST (Hall A7)

Presentation: GvHD Prophylaxis including ATG remains Standard of Care for HLA-compatible unrelated donor hematopoietic cell transplantation: results from a large randomized controlled trial comparing ATG and PTCy
Prof. Johannes Schetelig (Dresden, Germany)
Date & time: Saturday, 13 June, 18:15 - 18:30 CEST (Hall A6)


EHA program 2026
-
Find us at at our booth no. 38 at the EBMT 2026 in Madrid
IFEMA Madrid

You can find us at the event venue IFEMA Madrid in Pavillon 9 at booth no. 38. Our DKMS colleagues will be happy to answer your questions, explain our services and affirm our international commitment on site.


EBMT_Flyer.png
Website EBMT 2026
-
We take part in the WMDA Global Meetings 2026 in Madrid
NH Collection Madrid Eurobuilding

You can find our DKMS booth in the exhibition area of the NH Collection Madrid Eurobuilding in Madrid. We look forward to meeting you there!

WMDA_Flyer.png
Website WMDA Global Meetings 2026